Company ProfilePremium

BluGlass Limited

Company Profile Analysis

Ticker: BLG.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
BluGlass Limited - Company showcase

Year Founded & Workforce

2005

25 Employees

BluGlass Limited logo

BluGlass Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

BluGlass Limited Overview

BluGlass is a micro-cap, vertically integrated gallium nitride (GaN) visible laser diode developer and manufacturer with epitaxy operations in Sydney and a laser fabrication facility in Fremont, California. It describes itself as one of only a handful of end-to-end GaN laser manufacturers globally and one of just two GaN laser suppliers with US manufacturing, a position it is leveraging into US defence, aerospace, quantum, biotech and AI-infrastructure programs that increasingly require onshore supply. Its commercial model is "project-to-product": paid custom-development contracts (US Department of War CLAWS Hub, a US Tier-1 defence prime, a Fortune 500 data-storage company, Uviquity, TOPTICA, Coherent) intended to convert into recurring product supply. Revenue from customers remains small (A$4.1M in FY2026) and the company is loss-making (A$10.4M net loss), funded by equity raises and Australia's R&D Tax Incentive. A refreshed, US-oriented board led by Executive Chair Omer Granit recapitalised the company with A$14.6M in FY2026.


Company's own description (FY2026 Annual Report, paraphrased)

The FY2026 Directors' Report states that the Group's principal activity is the development and commercialisation of its visible GaN laser portfolio. This includes fulfilling product orders and foundry-service contracts, delivering technical milestones under customer-funded development programs, and advancing laser performance and manufacturing capability using both industry-standard MOCVD (metal-organic chemical vapour deposition) and BluGlass' proprietary low-temperature Remote Plasma Chemical Vapour Deposition (RPCVD) technology. The Group has operations in Australia and the USA, including a purpose-built production facility in Silicon Valley. ASX boilerplate describes BluGlass as a leading supplier of GaN laser diode products to the global photonics industry, focused on industrial, defence, bio-medical and scientific markets.

The Executive Chair's FY2026 letter frames the ambition as transforming BluGlass into a key onshore provider of critical photonic components to defence and aerospace, quantum, sensing and AI infrastructure, and signals intent to expand in the US and integrate complementary upstream technologies to move from component supplier toward systems provider.

Business model and revenue model

Revenue channelNatureRecognitionFY2026 (AUD)Strategic status
Laser Diode Project RevenueCustomer-funded custom development (NRE), government subcontracts (e.g., NCSU CLAWS Hub)Over time, pro rata2,552,791Core — the "project" leg of project-to-product
Laser Diode Product RevenueSales of laser diodes, gain chips, DFB lasers, bars, packaged devicesPoint in time498,212Core growth target
Foundry Services RevenueEpitaxy/wafer and process services for third parties (legacy)Point in time1,009,652Being exited ("deliberate transition away")
R&D Tax Incentive (other income)Australian refundable R&D tax offset on eligible AU and US activitiesAccrued when eligibility established6,116,957Non-customer funding; largest single income line

BluGlass earns revenue through four channels (FY2026 Annual Report, Note 2):

Mix characterisation: In FY2026, customer revenue was 63% project (development services), 25% foundry services and 12% product. There is no subscription revenue. Licensing/IP revenue has been episodic — notably a A$1.93M (US$1.28M) IP-rights transfer payment from a European wafer developer received in July 2024 (booked in FY2024 per the Q4 FY2024 4C). The company is therefore, today, predominantly a contract R&D and development-services business with an embryonic component-sales line, financially underpinned by R&D tax refunds.

Value chain position

BluGlass is vertically integrated across the GaN laser value chain:

  1. Epitaxy (wafer growth) — MOCVD and proprietary RPCVD, Silverwater, Australia.

  2. Device design — single-mode, multi-mode, DFB, gain chips, tunable and MOPA architectures.

  3. Wafer fabrication / front-end and back-end processing — Fremont, California fab (acquired 2022); contract-manufacturing capability brought in-house via the GaNWorks Foundry acquisition (completed early 2024).

  4. Testing and packaging — packaged form factors (e.g., TO-can, butterfly, bars; specific catalogue details below), including integrated laser + optical amplifier packages for the Tier-1 defence prime program.

Management states that around 85% of manufacturing steps are shared across product lines (FY2026 CEO letter), supporting platform scalability.

Customer types and end-markets

Customer typeNamed examples (from filings/announcements)
Government / defence agenciesUS Department of War (via NCSU-led CLAWS Hub, Microelectronics Commons); India Ministry of Defence (Solid State Physics Laboratory)
Defence primesUnnamed US Tier-1 aerospace and defence prime (avionics, navigation systems)
Large corporatesUnnamed Fortune 500 mass-capacity data-storage leader; Coherent (collaboration)
Photonics/quantum companiesTOPTICA Photonics Inc. (US division), Infleqtion, Uviquity
Research institutionsUniversity of Central Florida CREOL (repeat orders), Macquarie University (LiDAR project with Aurizn), North Carolina State University
AI infrastructureUnnamed stealth-mode optical interconnect developer (feasibility study); unnamed AI infrastructure customer (purchase order)

End-markets per management: defence and aerospace, quantum (computing and sensing), biotech/biomedical, scientific instrumentation, consumer electronics (AR), AI/data-centre optical interconnect, and data storage. Management states the US Government represents more than 60% of opportunities in its project pipeline, and investor materials (April 2026 placement presentation) state more than 80% of the pipeline is US-based.

Independent characterisation

BluGlass is best understood as a technically credible but sub-scale "option on visible GaN photonics" whose strategic value lies in (a) a rare US-located GaN laser fab, (b) a demonstrated ability to deliver bespoke high-fidelity visible lasers (DFB, single-mode, high-brightness MOPA), and (c) a growing roster of blue-chip development partners. The commercial model has not yet produced meaningful recurring product revenue — product sales were under A$0.5M in FY2026 — and the business consumed A$8.3M of operating cash flow in FY2026. The proprietary RPCVD technology, the company's founding thesis, is now a secondary differentiator; the FY2026 report says the company will continue to evaluate opportunities to leverage RPCVD where it supports shareholder value. The refreshed board's language about "inorganic opportunities" and moving "from component supplier to systems provider" suggests M&A may become a central lever.

Strategy

Stated strategy themes (FY2026 Annual Report, paraphrased)

  1. "Project-to-product." Paid custom-development programs get BluGlass lasers "designed in" to next-generation customer systems, intended to convert into multi-year product supply agreements. Management acknowledges the transition can be lengthy and "will often include inorganic growth."

  2. Leading US onshore visible laser company. Leverage the Fremont fab and approved CLAWS Hub supplier status to win US Government and defence-prime programs subject to sovereign supply-chain requirements.

  3. US Government engagement and non-dilutive funding. Michael Best Strategies engagement; advisory relationship with Major General John F. Wharton (US Army, ret.); targeting Department of War and Department of Energy decision-makers.

  4. Platform technology roadmap. Higher-power single-mode (MOPA), DFB, tunable lasers, longer wavelengths (aquamarine/green via UCSB SSLEEC licence), surface emitters for AI interconnects.

  5. From component supplier to systems provider. Integrate complementary upstream technologies; explore broader opportunities, including leveraging US manufacturing capabilities (board statements, Dec 2025 and Aug 2026).

  6. Recapitalisation and investor-base broadening. Completed A$14.6M FY2026 raise; US investor engagement; Board alignment through personal investment.

  7. Focus on core. Exit legacy foundry; divest majority of Semiconductor Australia conference vehicle.

Strategic initiatives — last 24 months

DateInitiativeTypeDetail
Oct 2024Uviquity JDAPartnership / developmentThree-phase JDA with Master Supply Agreement option
FY2025CLAWS Year 2Government programA$2.9M
2,025India MoD supplier approvalMarket entryUS$230k first order
Sep–Dec 2025Board refreshGovernance transformationUS-centred, investor-led board
Dec 202520:1 share consolidationCapital marketsRe-based share price from ~A$0.01 to ~A$0.20+
Jan 2026CLAWS Year 3Government programA$1.05M
FY2026UCSB SSLEEC licence (further agreement)IP / technologyAlGaN-layer long-wavelength visible laser IP
Mar 2026Tier-1 defence prime programCommercialA$1.25M
Mar 2026Michael Best StrategiesGovernment relationsDoW/DoE access
Apr 2026Fortune 500 collaborationCommercialA$1.3M
Apr–Jun 2026A$14.6M recapitalisationFundingPlacement, options, shortfall
Jul 2026US$1.5M Uviquity promissory noteStrategic investment6% interest, 12-month maturity
Jul 2026Semiconductor Australia divestmentPortfolio simplificationRetain 19.9% with branding rights and profit share
Sep 2026Coherent collaborationPartnershipA$286k co-development

ESG/sustainability commitments and cost programs

No formal sustainability targets or cost-reduction programs with quantified targets are disclosed. The FY2026 report notes a deliberate reallocation of resources from foundry services to customer programs. The going-concern note retains the option to scale back development activities if required.

Medium-term targets and guidance

No formal financial guidance is provided. Management's stated focus is converting the US$100M project pipeline (29 opportunities as of March–April 2026) into contracts. Historical aspirational targets have not been met: in 2021–22 management aimed to capture 6–10% of the global laser diode market by 2026 (Edison research cited a market estimate of A$849M and potential revenue of almost A$75M), and the 2022 fab acquisition was said to have the potential to bring forward positive cash flows to 2024/2025. FY2026 customer revenue was A$4.1M and the company remains cash-flow negative. This track record should temper reliance on pipeline figures.

Products & Services

Pricing is not publicly disclosed for any product. Launch dates are given where disclosed.

Laser Diode Products

Product / platformDescription and key capabilitiesTarget customersLaunch / latest milestone
Single-mode visible GaN lasersHigh beam-quality (single-spatial-mode) blue/violet/near-UV lasers for precision applicationsQuantum, sensing, biomedical, aerospaceWorld-record 1.25W single-mode (2025); 1.9W peak single-mode via MOPA (Q4 FY2026)
Multi-mode GaN laser diodesHigher-power broad-area emitters across visible wavelengthsIndustrial, scientific, defenceProduct suite launched Jan 2023 (Photonics West)
GaN laser diode barsSemi-custom multi-emitter barsResearch (e.g., UCF CREOL repeat orders, A$120k repeat order)Ongoing
GaN Distributed Feedback (DFB) lasersSingle-frequency, narrow-linewidth visible lasers; IP partly licensed from UCSB SSLEECQuantum (atomic clocks, sensing), defenceFirst alpha DFB order c.2024; packaged DFB + amplifier for Tier-1 prime (2026)
GaN gain chipsSemiconductor optical gain elements for external-cavity and MOPA systemsQuantum (Infleqtion initial order), defence primeInfleqtion PO FY2026; Tier-1 prime prototype testing passed
MOPA (master oscillator power amplifier) architecture450 nm single-mode oscillator + tapered amplifier; combines single-mode precision with high powerAerospace, defence, quantum, biomedical1.9W demonstration FY2026
High-peak-power CW tunable lasersNovel tunable GaN designs; PCT application filed FY2026Aerospace/marine/defence, quantum, biotechDevelopment/IP stage
Custom PIC-ready lasersHigh-precision single-frequency lasers for photonic integrated circuitsTOPTICA (NORDTECH Hub QUPICS program), UviquityTOPTICA order A$190k FY2026
Long-wavelength visible (aquamarine/green) lasersExtension of wavelength range using licensed UCSB SSLEEC AlGaN-layer IPQuantum sensing, biomedical, AR, defenceDemonstrated range extension FY2026; licence FY2026
GaN surface emittersEarly-stage feasibility for optical interconnectAI computing / data-centre infrastructure (stealth customer)Feasibility study FY2026

Development services (Laser Diode Projects)

ProgramCounterpartyValueScopeStatus
CLAWS Hub Years 1–3NCSU / US Department of War Microelectronics Commons (CHIPS and Science Act funded)A$6.5M (US$4.4M) cumulativeHigh-fidelity visible GaN lasers and integrated photonicsYear 3 underway (USFY2026); five-year program
Tier-1 defence prime programUnnamed US aerospace/defence primeA$1.25M (first A$560k PO)Packaged DFB lasers + gain chips (laser + optical amplifier) for dual-use aerospace14–20/24-month program from Mar 2026
Fortune 500 collaborationUnnamed mass-capacity data-storage leaderA$1.3M (four milestone instalments)Photonics R&D support12–18 months from Apr 2026
Uviquity JDAUviquity (US start-up; AlN PIC/deep-UV)Phase I A$1.2M (2024); Phase II A$1.4M (2026)Heterogeneously integrated PICs; wafer/chip processing; packaging; laser supplyPhase II from Q3 CY2026; Master Supply Agreement contemplated
Coherent collaborationCoherentA$286k (US$200k)Co-development of novel GaN device for scientific/medical marketsAnnounced 21 Sep 2026
India MoD SSPLIndian Ministry of DefenceUS$230kBenchmarking GaN laser diode fabrication processOngoing (referenced Apr 2026)
Ocean LiDARMacquarie University, Aurizn—Laser for subsurface water temperature and depth measurementStatus n/d
Applied EnergeticsApplied Energeticsn/d (MOU)Advanced defence/dual-use laser systemsStatus n/d

Foundry services (legacy, being exited)

Epitaxial growth and wafer services for third parties (including a European wafer developer to which IP was transferred in 2024). FY2026 revenue A$1.01M, down 40%; management stated the company reduced and ultimately exited these services.

RPCVD technology

Proprietary low-temperature, low-hydrogen, ammonia-free plasma deposition for III-nitride growth (originally 500–700°C versus >950°C for MOCVD). Historically pitched for LEDs, micro-LEDs, power electronics and tunnel-junction laser diodes (first RPCVD tunnel-junction laser diodes demonstrated c.2022). Currently a secondary/optional commercialisation path.

Financial Narrative

All A$M, fiscal years ending 30 June. Sources: Appendix 4E/Annual Reports FY2022–FY2026; FY2022–FY2024 revenue and operating cash flow lines from Stoxray/TipRanks aggregations of reported figures; FY2023–FY2024 cash and D&A from InvestSMART/Morningstar.

Income statement

Notes: Gross profit is not disclosed (expenses by nature; no COGS). EBITDA derived as net loss + D&A + finance cost − finance income (no tax expense). FY2022 net loss of A$9.36M is consistent with the FY2023 4E statement that the loss rose 25.6% to A$11.75M. FY2023 total income ~A$9.5M per Stonegate. The FY2025 per-share figure was restated from −0.59c to −11.74c after consolidation (the ×20 conversion of −0.59c gives −11.8c; the small difference reflects the restated weighted-average share count of 93.5M).

Margins and growth

Revenue CAGR (FY2022–FY2026, customer revenue): ~61% per annum (A$0.60M to A$4.06M). This flatters the trajectory: FY2024 included a one-off A$1.93M IP transfer, and FY2026 revenue fell 25%.

Balance sheet

Notes: Borrowings are Radium Capital (Innovation Structured Finance Co., LLC) loans secured against the R&D tax rebate, 16.5% interest, maturing 31 October 2026; A$2.41M (principal, interest, fees) was repaid 1 July 2026. Intangibles: A$12.13M in-process R&D fully impaired. There is no long-term financial debt.

Ratios (derived)

n/m = not meaningful (negative EBITDA/EBIT). Cash conversion cycle cannot be computed without COGS.

Commentary on trends, inflections and drivers

Persistent ~A$10–12M annual losses. Net losses have ranged between A$9.4M and A$11.8M for five years, with no structural inflection. FY2026's 5% improvement came mostly from a A$0.29M share-based payment credit (reversal of A$0.54M of expense on lapsed director performance rights), lower depreciation (A$2.83M vs A$3.29M) and lower consumables (A$2.70M vs A$3.17M) — not from revenue growth. Employee costs fell 6% to A$7.98M; board and secretarial fees rose 21% to A$0.66M and travel rose 76% to A$0.45M, reflecting the US-centred board and government-relations push.

Revenue quality. Customer revenue peaked at A$5.45M in FY2025. FY2026's decline reflects the foundry exit (−A$0.68M) and US government delays on projects (−A$0.84M). Product revenue (A$0.50M) remains immaterial relative to the cost base. Gross expenditure was A$20.87M in FY2026, roughly 5x customer revenue.

R&D Tax Incentive dependence. The refundable offset contributed A$6.05M (FY2025) and A$6.12M (FY2026), more than customer revenue in both years. Because the offset is a percentage of eligible spend, it partly scales with losses — it is a subsidy, not a commercial validation. The company pre-finances it through Radium Capital at 16.5%, which raised finance costs to A$0.59M.

Cash burn and funding. Operating cash outflow worsened 35% to A$8.30M in FY2026 as customer receipts fell 39%. Cash nearly doubled to A$11.34M only because of A$14.6M of equity raised. At the Q3 FY2026 quarter-end (31 March 2026), cash was just A$2.72M (Appendix 4C), illustrating how close the company came to a funding crunch before the April–June raise. Auditors' going-concern basis carries a material uncertainty in FY2026 (and the FY2025 commentary on Quartr also referenced going-concern risk).

Dilution. Shares on issue rose 57% in FY2026 (120.7M to 190.0M post-consolidation), and pre-consolidation shares had already expanded from ~1.8bn to 2.4bn in FY2025 via raises at A$0.013. A further 55.0M options (mostly A$0.38 strike, expiring May 2028) are outstanding — potentially ~A$20.9M of future funding if exercised, but at the cost of ~29% further dilution.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityCountryOwnership 30 Jun 2026Role

BluGlass Limited

Australia

Parent

Listed holding/operating company; Silverwater epitaxy and R&D

BluGlass Incorporated

United States

100%

US operations, Fremont fab, US government/defence contracting entity (e.g., India MoD supplier approval was in the name of BluGlass Inc)

Gallium Enterprises Pty Ltd

Australia

100%

Not described in sources accessed

EpiBlu Technologies Pty Ltd

Australia

100%

Former JV vehicle (2010)

Semiconductor Industry Australia Pty Ltd

Australia

100% (reduced to 19.9% on 7 Jul 2026)

Semiconductor Australia conference vehicle

Revenue by Segment

MetricFY2024FY2025FY2026

Laser Diode Project Revenue (AUD Mn)

—3.392.55

Laser Diode Product Revenue (AUD Mn)

—0.370.50

Foundry Services Revenue (AUD Mn)

—1.691.01

Total Revenue from Customers (AUD Mn)

4.625.454.06

R&D Tax Incentive Income (AUD Mn)

—6.056.12

Other Income incl. finance income (AUD Mn)

—0.200.30

Total Revenue + Other Income (AUD Mn)

10.1011.7010.48

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment Margins & Growth (%) and Revenue by Segment (%)

MetricFY2025FY2026

Project Revenue YoY growth (%)

—-24.7

Product Revenue YoY growth (%)

—35.5

Foundry Revenue YoY growth (%)

—-40.3

Project share of customer revenue (%)

62.262.9

Product share of customer revenue (%)

6.712.3

Foundry share of customer revenue (%)

31.024.9

R&D Tax Incentive share of total income (%)

51.758.4

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from customers (AUD Mn)

0.601.154.625.454.06

Total revenue and other income (AUD Mn)

—9.5010.1011.7010.48

Depreciation and amortisation (AUD Mn)

—3.903.003.292.83

Finance cost (AUD Mn)

———0.440.59

EBITDA, derived (AUD Mn)

———-7.30-6.98

Pre-tax income (AUD Mn)

-9.36-11.75-10.14-10.98-10.39

Net income (AUD Mn)

-9.36-11.75-10.14-10.98-10.39

EPS basic, as reported (A$ cents)

-0.89-0.86-0.63-0.59-7.51

EPS basic, consolidation-adjusted (A$ cents)

-17.80-17.20-12.60-11.74-7.51

EPS diluted (A$ cents, adjusted)

-17.80-17.20-12.60-11.74-7.51

Dividends per share (A$ cents)

00000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue growth YoY (%)

66.389.5302.918.0-25.5

Net margin on customer revenue (%)

-1,547-1,025-220-201-256

Net margin on total income (%)

—-124-100-94-99

EBITDA margin on customer revenue, derived (%)

———-134-172

Operating margin, InvestSMART definition (%)

—-662.6-93.9-133.9—

Balance Sheet and Per-Share Data

MetricFY2023FY2024FY2025FY2026

Total assets (AUD Mn)

——23.9327.41

Cash and equivalents (AUD Mn)

4.265.575.7411.34

Trade and other receivables incl. R&D rebate (AUD Mn)

——7.777.70

Short-term borrowings (AUD Mn)

——3.054.54

Lease liabilities current (AUD Mn)

——0.780.87

Lease liabilities non-current (AUD Mn)

——3.272.65

Total debt incl. leases (AUD Mn)

——7.108.06

Net debt / (net cash) (AUD Mn)

——1.37-3.28

Total equity (AUD Mn)

—14.8911.5914.41

Goodwill and intangibles (AUD Mn)

——00

Working capital (AUD Mn)

——7.1311.75

Accumulated losses (AUD Mn)

—98.06109.03119.42

Issued capital (AUD Mn)

—112.58120.08134.57

NTA per share (A$ cents, post-consolidation)

——15.1716.76

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Receipts from customers (AUD Mn)

———6.914.23

R&D tax rebate received (AUD Mn)

———5.376.07

Operating cash flow (AUD Mn)

-6.26-11.88-6.95-6.15-8.30

Capex — plant and equipment (AUD Mn)

———1.811.21

Free cash flow, derived (AUD Mn)

———-7.96-9.51

Equity raised, net (AUD Mn)

———7.4514.61

Net borrowings (AUD Mn)

———1.901.49

Lease principal repaid (AUD Mn)

———0.781.01

Dividends paid (AUD Mn)

00000

Share buybacks (AUD Mn)

00000

Returns & Leverage Ratios (%)

RatioFY2025FY2026

ROE (%; net loss / average equity)

-82.9-79.9

ROA (%; net loss / year-end assets)

-45.9-37.9

ROIC (%)

ROIC (%)n/mn/m

Current ratio (x)

1.952.34

Debt / equity incl. leases (x)

0.610.56

Net debt / EBITDA (x)

Net debt / EBITDA (x)n/mn/m

Interest coverage (x)

n/m

n/m

Asset turnover (x; customer revenue / year-end assets)

0.230.15

Revenue by Region and Revenue by Region (%)

IndicatorFY2025FY2026

Accumulated tax losses — Australia (AUD Mn)

25.8326.59

Accumulated tax losses — United States (AUD Mn)

6.0610.76

US share of pipeline opportunities by value (%)

—80

US Government share of pipeline opportunities (%)

—60

Valuation Snapshot

MetricValue

52-week range

A$0.175 – A$0.55

Calendar 2026 YTD (to Aug 2026)

approx. +40% to +57% (from A$0.235 starting price)

FY2026 return (unadjusted data shows +3,567%, distorted by consolidation)

Approx. +83% on consolidation-adjusted basis (A$0.18 to A$0.33; derived from A$0.009 × 20)

1-year (to Aug 2026)

approx. +62.5% (Investing.com)

FY2025 shareholder return

-72.8% (InvestSMART)

FY2024 shareholder return

-19.4% (InvestSMART)

FY2023 shareholder return

57.8% (InvestSMART)

3-year return

Strongly negative (cumulative FY2024–FY2026 approx. -73% derived from annual figures above; indicative only)

Metric

FY2023

Annual shareholder return (%)

57.8

Valuation Snapshot by Multiple

MultipleValueBasis

Market capitalisation

~A$63M

Price × shares

Enterprise value

~A$60M

Market cap + A$8.06M debt incl. leases − A$11.34M cash (30 Jun 2026)

EV / Sales (customer revenue FY2026)

~14.7x

A$4.06M

EV / total income (FY2026)

~5.7x

A$10.48M

P/B

~4.4x

Equity A$14.41M

P/E

n/m

Loss-making

EV/EBITDA

n/m

Negative EBITDA

Obligation Details

ObligationAmount (AUD Mn)Maturity / terms

Radium Capital R&D-secured loans

4.54

31 Oct 2026; 16.5% p.a.; A$2.41M repaid 1 Jul 2026; facility redrawable

Lease payments within 1 year (undiscounted)

1.32

FY2027

Lease payments 1–5 years (undiscounted)

2.89

FY2028–FY2031

Lease payments >5 years (undiscounted)

0.22

To Feb 2033 (Silverwater)

Debt maturity bucket (AUD Mn)

FY2027

FY2028-FY2031

Borrowings and leases (undiscounted)

5.862.89

Share Price & Returns

DateInstrumentPrice (post-consolidation equivalent)Gross proceeds (AUD Mn)

FY2024

Placement + SPP

—10.17

May–Jul 2025

Placement + SPP + shortfall

A$0.26 (A$0.013 pre-consolidation)

7.63

Sep 2025–May 2026

A$0.26 option exercises

A$0.26

5.06

Apr–Jun 2026

Two-tranche placement

A$0.24

8.05

Jun 2026

Option shortfall (Amery Partners)

A$0.26

1.50

Analyst Conclusions

Management guidance

No quantitative financial guidance. Management targets conversion of the US$100M pipeline into revenue-generating contracts, new and repeat orders, technology roadmap progress (higher power, longer wavelengths), expanded US Government engagement and access to non-dilutive grants, and investment in new equipment and personnel. Strongest demand is cited in defence and aerospace, quantum, biotech and consumer electronics.

Consensus expectations

Not available (no consensus coverage).

Bull case

  1. Design-in conversion: Three concurrent programs with large counterparties (Tier-1 prime A$1.25M, Fortune 500 A$1.3M, Uviquity Phase II A$1.4M) plus the Coherent collaboration create multiple shots at production supply agreements within 12–24 months; a single volume supply agreement could multiply product revenue from A$0.5M.

  2. Strategic scarcity value: As one of two US-located GaN laser manufacturers with Department of War-approved supplier status, BluGlass's fab and IP could command a strategic premium; at ~A$60M EV, the company trades near the replacement cost management cited for the fab alone (~US$40M) plus IP.

  3. Funded runway and aligned board: A$11.3M cash, net cash position, ~A$6M annual R&D rebate, and A$20.9M of in-the-money-contingent A$0.38 options provide 12–18 months of runway; the board has invested personally (A$2.27M) and has capital-markets networks to pursue non-dilutive US funding and M&A.

Bear case

  1. Structural cash burn without commercial inflection: Five consecutive years of ~A$10–12M losses, customer revenue down 25% in FY2026, and Q4 FY2026 customer receipts of only A$0.20M demonstrate that the project model has not yet scaled; historic targets (6–10% market share and positive cash flow by 2024/25) were missed by wide margins.

  2. Dilution treadmill: Share count up 57% in FY2026 alone, plus 55M options outstanding; going-concern material uncertainty persists, and every year of operation at the current burn rate requires ~A$8–10M of new capital.

  3. Governance and capital-allocation risk: A non-majority-independent board led by an executive chair, overlapping investor relationships among directors, and a US$1.5M loan to a start-up customer raise questions about capital discipline; a pivot to "inorganic" growth could add complexity and further dilution.

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
Oct 2026Q1 FY2027 Appendix 4C — customer receipts trend; repayment of Radium loans by 31 Oct 2026
Oct 2026 onwardsReceipt of FY2026 R&D Tax Incentive refund (~A$6.13M receivable)
Nov 20262026 AGM — approval of piggyback options and CEO LTI; board composition votes; any "first strike" risk on remuneration
H1 FY2027CLAWS Hub Year-4 award (US federal FY2027 budget timing)
H1–H2 FY2027Tier-1 defence prime program phase-2 order; Fortune 500 milestone payments
FY2027Uviquity Master Supply Agreement negotiation; repayment of US$1.5M promissory note (Jul 2027)
FY2027Non-dilutive US Government grant award (DoW/DoE) — evidence of Michael Best engagement payoff
FY2027Any announced M&A or strategic transaction
Feb 2027H1 FY2027 half-year report — revenue mix, cash burn
OngoingExercise of A$0.38 options (expire 31 May 2028) — share price must exceed A$0.38

Analyst verdict

BluGlass enters FY2027 in a better position than at any time in the past three years — but that bar is low. The company has executed a credible operational and governance reset: a US-centred board, a recapitalisation that lifted cash to A$11.3M and eliminated net debt, and a second half of FY2026 that produced five new development contracts worth just under A$5.2M with counterparties of genuine quality (a US Tier-1 defence prime, a Fortune 500 company, TOPTICA, Uviquity, and, subsequently, Coherent). Its US fab and Department of War credentials are scarce assets in a world prioritising sovereign photonics supply, and its single-mode and DFB results show real technical capability.

The financial reality, however, has not changed. Customer revenue of A$4.1M fell 25% in FY2026, product sales remain below A$0.5M, the R&D Tax Incentive is the largest income line, operating cash burn rose to A$8.3M, and the auditors' going-concern basis carries a material uncertainty. The project-to-product model has been the stated strategy since at least 2023, and management's own earlier aspirations — significant market share and positive cash flow by 2024–26 — have not materialised. Pipeline figures (US$100M; earlier >A$154M) should be treated as indicative rather than predictive, given conversion rates to date.

At ~A$60M enterprise value, the market is pricing BluGlass as a strategic option rather than an operating business. That option has value: a single production supply agreement, a meaningful non-dilutive US award, or a strategic transaction could re-rate the stock. Absent those, the base case is continued annual capital raising and dilution. Our assessment is that BluGlass is a high-risk, binary, event-driven speculation. The key evidence to watch over the next 12 months is not new development contracts, but the first multi-year product supply agreement and a sustained rise in quarterly customer receipts above ~A$2M.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedIndependenceBackgroundEducation

Omer Granit

Executive Chair

Director 15 Sep 2025; Exec Chair 10 Nov 2025

Not independent (executive; engaged as independent contractor)

Partner, EnPar Capital (New York); co-founder/managing member, June 76 (NY/Tel Aviv investment firm); founded MIXER (co-working) and West 4 Capital (UK hedge fund); ex-White & Case M&A attorney; NED of Amaero (ASX: 3DA) since Jan 2023

LLM (NYU, valedictorian); LLB and BA, Reichman University; admitted in New York and Israel

James (Jim) Haden

CEO & Managing Director

President Sep 2021; CEO Mar 2023; Director 9 Dec 2025; MD 13 Jul 2026

Not independent

30+ years laser diode industry; senior roles at Kyocera SLD, nLIGHT, Coherent, JDS Uniphase (now Lumentum)

MS and BS, University of Southern California (Quantum and Solid-State Physics)

Lucy Robb Vujcic

Independent NED; Audit & Risk Committee Chair; Remuneration Committee member

10 Nov 2025

Independent

Commercial barrister; corporate law, defence procurement, government contracting, international arbitration; ex-Skadden Arps associate; former NED Amaero (Oct 2022–Oct 2024)

BA/LLB (First Class Hons), University of Sydney; LLM, NYU; FGIA

Ata Gokyildirim

Independent NED; Remuneration Committee Chair; Audit & Risk Committee member

10 Nov 2025

Independent (per company)

Chief Revenue Officer, Insait IO; former Chair, Prima BioMed (now Immutep); roles at Forter, Sedric, LoudNClear

B Comm

Yam Rubenstein

NED

21 Aug 2026

Not stated; analyst view: not independent given co-control of J76 BLG LLC with Executive Chair

Founder/CEO 102 Percent Ltd; 10+ years Deputy CEO, Migdal Capital Markets; advisory board, Cyabra (Nasdaq); co-founder June 76

Bachelor of Commerce

Executive Leadership Team

NameTitleNotes

Jim Haden

CEO & Managing Director

See above

Samuel Samhan

Chief Financial Officer

Investor/media contact on 2026 announcements

Ian Mann

Chief Operations & Technology Officer

Long-tenured technical executive

Brad Siskavich

Vice President

US-based (inferred from remuneration currency effects; not confirmed)

Stefanie Winwood

Investor relations/communications contact (2025 announcements)

Not KMP

Andrew Palfreyman

Company Secretary (contracted)

From 6 Jan 2026; predecessor Patricia Vanni (Jul 2024–Jan 2026)

Directors' Remuneration

ExecutiveCash salaryCash STISTI share-basedSuperannuationLTI share-basedTotal% share-based

Omer Granit (Exec Chair)

296,6880000296,6880

Jim Haden (CEO)

411,485073,91331,96630,107547,47119.0

Samuel Samhan (CFO)

291,200055,40139,98925,445412,03519.6

Ian Mann (COO/CTO)

294,899053,08240,28524,916413,18218.9

Brad Siskavich (VP)

311,418050,72262,85624,743449,73916.8

Total executives

1,605,6900233,118175,096105,2112,119,115—

Executive total remuneration (AUD)

FY2025

FY2026

—————

Jim Haden

620,826547,471—————

Samuel Samhan

394,316412,035—————

Ian Mann

396,384413,182—————

Brad Siskavich

466,338449,739—————

All executives

1,877,8632,119,115—————

Major Shareholders

HolderSharesApprox. % of 190.0M

J76 BLG LLC (Granit and Rubenstein relevant interest)

8,333,3344.4

Jim Haden (direct + ESS trust)

1,389,0380.7

Ian Mann

755,3990.4

Ata Gokyildirim

625,0000.3

Brad Siskavich

470,6950.2

Samuel Samhan

345,0000.2

Total disclosed board/KMP

11,918,4666.3

Competitive Landscape

Key Competitors

CompetitorCountryRelevance to BluGlassPositioning vs BluGlass

Nichia Corporation

Japan

Dominant global GaN laser diode supplier (blue/violet; projectors, industrial)

Massive scale and cost leadership; private, segment data not disclosed

Kyocera SLD Laser

USA (Kyocera subsidiary)

GaN laser light sources (laser lighting); US-based (California) — plausibly the other US GaN laser manufacturer management references

Larger, backed by Kyocera; CEO Haden is an alumnus

ams OSRAM

Austria/Germany

Blue/green GaN laser diodes for projection, automotive, industrial

—

Sharp (Fukuyama laser operations)

Japan

GaN violet/blue laser diodes

Established volume supplier

Ushio

Japan

Visible laser diodes (red/green/blue)

Broad lamp/laser portfolio

Coherent

USA

Lasers/photonics giant; now also a BluGlass collaborator

—

nLIGHT

USA

US-based semiconductor laser manufacturer (primarily infrared) and defence laser systems

—

NUBURU

USA

Blue industrial lasers (uses GaN diodes from third parties)

Potential customer/competitor at system level; financially distressed

Exalos / other SLD makers

Switzerland

Visible superluminescent diodes

Niche competitor for some sensing applications

Enkris Semiconductor

China

GaN epitaxy (CB Insights-listed competitor)

Competes in epitaxy/foundry rather than lasers

Chinese GaN laser makers (e.g., multiple domestic suppliers)

China

Low-cost blue laser diodes

Excluded from many US defence programs by sourcing rules — a BluGlass advantage

Peer Comparison FY2026

MetricBluGlass FY2026Coherent FY2025nLIGHT FY2024ams OSRAM FY2024

Revenue (local currency, M)

4.06 (A$)

5810 (US$)

199 (US$)

3430 (EUR)

Revenue growth (%)

-25.5———

Net margin (%)

-256———

Recent Developments

--

Company Snapshot

25

Employees

2005

Founded

Silverwater, Australia

Headquarters

SWOT Analysis

Strengths

  • US manufacturing footprint: Owns and operates a ~19,000 sq ft GaN laser fab in Fremont, CA, acquired for US$2.5M versus a management-cited ~US$40M replacement cost (ASX, Mar 2022).
  • US Government credentials: A$6.5M (US$4.4M) cumulative CLAWS Hub subcontracts across three years; approved off-ramp commercial supplier (ASX, 12 Jan and 9 Mar 2026).
  • Technical leadership claims: 1.9W peak single-mode blue output, a 52% improvement on its own prior 1.25W record (FY2026 Annual Report).
  • Blue-chip development partners: Tier-1 defence prime (A$1.25M), Fortune 500 data-storage leader (A$1.3M), Coherent (A$286k), TOPTICA (A$190k), Infleqtion (initial PO) — FY2026 report and ASX Sep 2026.
  • Strengthened balance sheet: Cash A$11.34M at 30 June 2026 (+98%); net cash of A$3.28M after all debt and leases; current ratio 2.34x (FY2026 Annual Report).
  • IP portfolio: 50–51 granted patents in 9 families plus UCSB SSLEEC licences (FY2026 Annual Report).
  • Aligned board investment: Board and management contributed A$2.27M to the June 2026 placement; J76 BLG LLC holds 8.33M shares (FY2026 Note 18, Remuneration Report).

Weaknesses

  • Persistent losses: Net losses of A$9.4–11.8M every year from FY2022 to FY2026; accumulated losses A$119.4M (FY2026 Note 20).
  • Tiny product revenue: Product sales A$0.50M in FY2026 — 12% of customer revenue and 2.4% of gross expenditure (FY2026 Note 2).
  • Revenue decline: Customer revenue fell 25.5% to A$4.06M in FY2026; customer receipts fell 39% to A$4.23M (FY2026 Directors' Report).
  • Going-concern material uncertainty: Explicitly stated in FY2026 financial statements (Note 1).
  • Subsidy dependence: R&D Tax Incentive (A$6.12M) exceeded customer revenue by 51% in FY2026.
  • Governance concentration: Executive chair; only 2 of 5 directors independent; two directors co-control the largest disclosed insider holding (FY2026 Annual Report).
  • Missed historical targets: 2021–22 ambition of 6–10% laser diode market share by 2026 and positive cash flow by 2024/25 not achieved (Edison research; ASX Mar 2022).

Opportunities

  • US$100M pipeline of 29 opportunities, >80% US-based, >60% US Government (Apr 2026 investor presentation; ASX Mar 2026).
  • Uviquity Master Supply Agreement — the JDA contemplates a follow-on supply agreement, the clearest path to recurring product revenue (ASX, 22 Oct 2024; 16 Jul 2026).
  • Tier-1 defence prime design-in — successful program completion (14–24 months) could lead to production orders for dual-use aerospace systems (ASX, 9 Mar 2026).
  • Non-dilutive US funding via DoW/DoE programs facilitated by Michael Best Strategies (FY2026 Annual Report).
  • AI infrastructure — feasibility study on GaN surface emitters for optical interconnect (FY2026 Annual Report).
  • Option exercise funding: 55.0M options at A$0.38 expiring May 2028 could provide ~A$20.9M if exercised (FY2026 Directors' Report).
  • Inorganic growth / strategic interest: Board signals exploring broader opportunities; rare US GaN laser fab could be an acquisition target for larger photonics players.

Threats

  • US budget volatility: H1 FY2026 shutdown and continuing resolution directly reduced project revenue (FY2026 Annual Report).
  • Further dilution: Shares on issue grew 57% in FY2026 (to 190.0M) after ~1,000M+ pre-consolidation shares were issued in FY2025 (FY2026 Note 18).
  • Refinancing risk: A$4.54M Radium loans mature 31 October 2026 at 16.5% (partially repaid; FY2026 Note 16).
  • Incumbent competition from Nichia, ams OSRAM, Kyocera SLD with orders-of-magnitude larger scale.
  • Partner disintermediation: Coherent and TOPTICA possess deep photonics capability and could vertically integrate.
  • Customer financing risk: US$1.5M lent to Uviquity, a venture-backed start-up that is also a key customer (FY2026 Note 29).
  • Key-person risk: Strategy heavily dependent on CEO Haden's industry network and Executive Chair Granit's capital-markets network.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr–May 2025Placement at A$0.013 (pre-consolidation) raising A$2.31M, with attaching optionsDeeply discounted (18.75% to last close) emergency-style raise
Jun 2025Share Purchase Plan raises A$3.82M; directors' placement A$44kRetail support
30 Jun–1 Jul 2025A$1.5M SPP shortfall placed (153.8M pre-consolidation shares)Completed FY2025 raise (~A$7.6M total)
Jun quarter 2025First Indian Government order; pipeline cited at 29 opportunities worth >A$154MGeographic diversification
Mid-20251,250 mW single-mode GaN laser world recordTechnical leadership
27 Aug 2025FY2025 results: record income A$11.7M; loss A$10.98M; NTA per share nearly halved (pre-consolidation)Persistent losses; going-concern risk flagged
15 Sep 2025Omer Granit appointed to Board (replaces Vivek Rao)Start of board refresh
Oct 2025Semiconductor Australia 2025 hostedEcosystem profile
10 Nov 2025Granit Executive Chair; Walker and Wilks resign; Vujcic and Gokyildirim appointedGovernance overhaul; AGM resolutions withdrawn
24 Nov 2025AGM approves 1:20 consolidation; FY2025 Remuneration Report passes (94.53%)Capital structure reset
4 Dec 2025Share consolidation completedShare price re-based
9 Dec 2025Haden joins Board; Pelaprat resigns; Granit says company at a "critical crossroads"Candid acknowledgement of commercialisation hurdles
24 Dec 2025First Radium Capital R&D loan (16.5%)Liquidity bridge during US shutdown delays
6 Jan 2026Company Secretary change (Palfreyman replaces Vanni)Administrative
12 Jan 2026CLAWS Hub Year-3 extension A$1.05MUS government relationship sustained, but Year-3 value is ~64% below Year 2 (A$2.9M)
H1 FY2026US Government shutdown and continuing-resolution delays slow contract signingsRevenue headwind
20 Feb 2026Second Radium Capital loanAdditional liquidity
Q3 FY2026TOPTICA A$190k order for custom PIC lasers (NORDTECH QUPICS)Quantum ecosystem
3–6 Mar 2026Share price rises from A$0.23 to A$0.36; ASX price query; trading haltLeak/anticipation of customer order
9 Mar 2026Tier-1 defence prime A$1.25M program; first A$560k POLargest industry (non-government) program
19 Mar 2026Michael Best Strategies engagedUS policy access
7 Apr 2026Fortune 500 data-storage A$1.3M collaborationLarge-corporate validation
13–30 Apr 2026Placement Tranche 1 at A$0.24Upsized raise
29 Apr 2026Q3 FY2026 4C: cash A$2.72M; op outflow A$3.21MCritically low cash before raise
31 May 2026A$0.26 options expire; A$5.06M exercisedStrong option conversion
1–5 Jun 2026A$1.5M shortfall with Amery PartnersTotal option-related proceeds A$6.56M
10–16 Jun 2026Placement Tranche 2 (incl. A$2.27M board/management)Total placement A$8.05M
Q4 FY20261.9W single-mode world record; Infleqtion order; AI interconnect feasibility study; UCSB long-wavelength licenceTechnology and pipeline breadth
1 Jul 2026A$2.41M Radium tranche repaidDeleveraging
7 Jul 2026Semiconductor Australia majority divestedFocus
13 Jul 2026Haden appointed Managing DirectorUS-style structure
16 Jul 2026Uviquity Phase II A$1.4MProgram progression toward supply
15 Jul 2026US$1.5M investment in Uviquity (promissory note)Customer financing — raises circularity questions
31 Jul 2026Q4 FY2026 4C: cash A$11.48M; receipts A$201k; op outflow A$4.46MQuarterly receipts very low
21 Aug 2026Yam Rubenstein appointed NEDFurther investor-aligned board seat
31 Aug 2026FY2026 Annual Report and 4E: loss A$10.39M; material going-concern uncertaintyResults
21 Sep 2026Coherent collaboration A$286kBlue-chip validation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment: Total Revenue from Customers fell from AUD 4.6 Mn in FY2024 to AUD 4.1 Mn in FY2026.
BluGlass Limited — Revenue by Segment
Series (AUD Mn)FY2024FY2025FY2026
Total Revenue from Customers4.65.54.1
Total Revenue + Other Income10.111.710.5
Laser Diode Project Revenue—3.42.6
Laser Diode Product Revenue—0.40.5
Foundry Services Revenue—1.71
R&D Tax Incentive Income—6.16.1
Other Income incl. finance income—0.20.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. BluGlass FY2026 Appendix 4E and Annual Financial Report (31 Aug 2026) (investorpa.com)
  2. BluGlass FY2025 Appendix 4E and Annual Report (27 Aug 2025) (announcements.asx.com.au)
  3. BluGlass FY2024 Appendix 4E and Annual Report (27 Aug 2024) (announcements.asx.com.au)
  4. BluGlass FY2023 Appendix 4E and Annual Report (30 Aug 2023) (announcements.asx.com.au)
  5. BluGlass FY2022 Appendix 4E (24 Aug 2022) (asx.com.au)
  6. BluGlass FY2022 Annual Report (announcements.asx.com.au)
  7. ASX: Option shortfall agreement (1 Jun 2026) (announcements.asx.com.au)
  8. ASX: ~A$6.6M from options (5 Jun 2026) (bulletin.webull.com)
  9. ASX: Uviquity Phase II (16 Jul 2026) (bulletin.webull.com)
  10. ASX: Coherent collaboration (21 Sep 2026) (investorpa.com)
  11. ASX: Fortune 500 agreement (7 Apr 2026) (bulletin.webull.com)
  12. ASX: Tier-1 defence prime program (9 Mar 2026) (bulletin.webull.com)
  13. ASX: CLAWS Year-3 extension (12 Jan 2026) (bulletin.webull.com)
  14. ASX: Haden appointed Executive Director (9 Dec 2025) (bulletin.webull.com)
  15. ASX: Uviquity JDA Phase I (22 Oct 2024) (announcements.asx.com.au)
  16. InvestSMART announcement summaries (Q4 FY2026 4C; Q3 FY2026 4C; price query; trading halt): ; .../2518856 ; .../2498653 ; .../2498472 (investsmart.com.au)
  17. InvestSMART share price history and financials · investsmart.com.au
  18. Quartr event summaries (FY2026, Q4 FY2026, Q3 FY2026) · quartr.com · quartr.com
  19. Semiconductor Today (2006 IPO; 2008 CEO change; 2022 fab; 2024–2026 updates) · semiconductor-today.com · dev.semiconductor-today.com · semiconductor-today.com · semiconductor-today.com · semiconductor-today.com · semiconductor-today.com · semiconductor-today.com · semiconductor-today.com
  20. Compound Semiconductor · compoundsemiconductor.net
  21. Defence Connect (defenceconnect.com.au)
  22. Australian Manufacturing (fab acquisition; tag pages) · australianmanufacturing.com.au
  23. Edison Investment Research · edisongroup.com
  24. Stonegate Capital Partners (Dec 2023) (api.newsfilecorp.com)
  25. SmallCaps (Indian MoD; Tier-1 prime) · smallcaps.com.au
  26. StockAnalysis (BUGLF) (stockanalysis.com)
  27. TipRanks revenue history (tipranks.com)
  28. Stoxray financial history (stoxray.com)
  29. PitchBook profile (pitchbook.com)
  30. CB Insights profile (cbinsights.com)
  31. ROIC.ai profile (roic.ai)
  32. Motley Fool AU (BLG) (fool.com.au)
  33. FMP Momentum Research (Jun 2026) (finermarketpoints.com)
  34. StockWireX (Apr 2026 placement presentation summary) (stockwirex.com)
  35. Strawman forum (FY2025 report discussion; secondary) (strawman.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.